person · Reporting owner
MARLETT CHRISTOPHER A
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cue Biopharma, Inc.CUE · Entity 6301 | Director | January 02, 2020 | January 06, 2020 |
| EXOZYMES INC.IZTC · Entity 1147 | Director · 10% owner | November 08, 2024 | November 19, 2024 |
| MDB Capital Holdings, LLCMDBH · Entity 7469 | Director · Co-Founder · 10% owner | May 01, 2026 | May 04, 2026 |
| Paradium.AI, Inc.MVEN · Entity 7275 | Director · 10% owner | December 05, 2017 | December 11, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cue Biopharma, Inc.
Report date January 02, 2020 · Filed January 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.31 · Expires 2030-01-02 | Direct | 8,000 |
Reported balance
After 2020-01-02 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-01-02 · Grant · Acquired 8,000 · Balance 8,000 F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy.
EXOZYMES INC.
Report date November 08, 2024 · Filed November 19, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 3,808,476 |
Reported balance
Holding disclosure · report date 2024-11-08 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,808,476 F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| SAFE for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $6.40 · Expires 2024-11-30 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Warrant for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2025-06-22 | IndirectSee Footnote | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $1.22, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC. F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC. |
| Stock Options for Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $2.44 · Expires 2028-01-31 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2024-11-08 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance Not disclosed F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter, and are fully vested on January 31, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held by MDB Capital Holdings, LLC, over which the Reporting Person has voting and dispositive authority. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F2: The SAFE converts into Common Stock upon the closing of a public offering of IZTC's securities. The Reporting Person disclaims any interest in the shares except to the extent of his pecuniary interests in MDB Capital Holdings, LLC.
F3: The warrant is held by MDB Capital Holdings, LLC and is exercisable at $1.22, until June 22, 2025. The Reporting Person disclaims any interest in the shares underlying the warrant except to the extent of his pecuniary interest in MDB Capital Holdings, LLC.
F4: The shares underlying the grant vest at the rate of 1,299 shares each quarter, and are fully vested on January 31, 2026.
MDB Capital Holdings, LLC
Report date May 01, 2026 · Filed May 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $3.56 · Expires 2036-05-01 | IndirectSee Footnote | 1,000,000 |
Reported balance
After 2026-05-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 100,000 · Balance 1,000,000 F1: 100,000 Class A Shares will vest as follows: 20,000 shares vest one year after grant date and the remainder vest in equal quarterly installments of 5,000 shares after each completed subsequent annual quarter of Continuous Service (as defined in the 2022 Equity Performance Plan). F2: Issued to the spouse. |
Filing footnotes · ownership attribution and instrument terms
F1: 100,000 Class A Shares will vest as follows: 20,000 shares vest one year after grant date and the remainder vest in equal quarterly installments of 5,000 shares after each completed subsequent annual quarter of Continuous Service (as defined in the 2022 Equity Performance Plan).
F2: Issued to the spouse.
Paradium.AI, Inc.
Report date December 05, 2017 · Filed December 11, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,033,279 |
Last balance in matching sequence
After 2017-12-05 transaction · row 5
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
5 source rowsRow 1 · 2017-12-05 · Purchase · Acquired 3,000 · Balance 3,005,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 2 · 2017-12-05 · Purchase · Acquired 5,000 · Balance 3,010,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 3 · 2017-12-05 · Purchase · Acquired 10,000 · Balance 3,020,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 4 · 2017-12-05 · Purchase · Acquired 5,000 · Balance 3,025,449 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. Row 5 · 2017-12-05 · Purchase · Acquired 7,830 · Balance 3,033,279 F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 827,541 shares held by Christopher A. Marlett Living Trust and 1,027,541 shares held by Christopher A. Marlett IRA.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 01, 2026 Filed May 4, 2026 21:37 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | GrantEmployee Stock Option · Derivative | 100,000 | $0.00 Strike: $3.56 | $0.00 |
DisclosureSEC source: 0001493152-26-021163 · ownership.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 1,000,000 Underlying: Class A · 100,000 shares Expires 2036-05-01 F1 · security: 100,000 Class A Shares will vest as follows: 20,000 shares vest one year after grant date and the remainder vest in equal quarterly installments of 5,000 shares after each completed subsequent annual quarter of Continuous Service (as defined in the 2022 Equity Performance Plan). F2 · ownership.nature: Issued to the spouse. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 01:24 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,213 | $3.50 | $4,245.50 |
DisclosureSEC source: 0001493152-26-000480 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,933 F1 · price: The reported price in Column 4 is an average purchase price. The shares acquired on January 2, 2026 were purchased in multiple transactions at prices ranging from $3.42 to $3.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| December 31, 2025 Filed Dec 31, 2025 21:34 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 4,387 | $3.35 | $14,696.45 |
DisclosureSEC source: 0001493152-25-029816 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,720 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on December 31, 2025 were purchased in multiple transactions at prices ranging from $3.34 to $3.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote Read SEC document |
| December 30, 2025 Filed Dec 31, 2025 21:34 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 4,400 | $3.18 | $13,992.00 |
DisclosureSEC source: 0001493152-25-029816 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,333 F1 · price: The reported price in Column 4 is an average purchase price. The shares acquired on December 30, 2025 were purchased in multiple transactions at prices ranging from $3.17 to $3.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| October 06, 2025 Filed Oct 7, 2025 13:21 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,725 | $3.41 | $5,882.25 |
DisclosureSEC source: 0001493152-25-017232 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 157,933 F3 · price: The reported price in Column 4 is an average purchase price. The shares acquired on October 6, 2025 were purchased in multiple transactions at prices ranging from $3.39 to $3.43 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| October 03, 2025 Filed Oct 7, 2025 13:21 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 2,275 | $3.35 | $7,621.25 |
DisclosureSEC source: 0001493152-25-017232 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 156,208 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on October 3, 2025 were purchased in multiple transactions at prices ranging from $3.34 to $3.35 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 29, 2025 Filed Aug 30, 2025 01:58 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,645 | $3.52 | $5,790.40 |
DisclosureSEC source: 0001641172-25-026105 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 153,933 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on August 29, 2025 were purchased in multiple transactions at prices ranging from $3.50 to $3.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 28, 2025 Filed Aug 30, 2025 01:58 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,575 | $3.56 | $5,607.00 |
DisclosureSEC source: 0001641172-25-026105 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 152,288 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 23:16 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,288 | $3.40 | $4,379.20 |
DisclosureSEC source: 0001641172-25-025741 · ownership.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 150,713 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 26, 2025 Filed Aug 27, 2025 23:16 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,414 | $3.35 | $4,736.90 |
DisclosureSEC source: 0001641172-25-025741 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 149,425 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 25, 2025 Filed Aug 27, 2025 23:16 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,232 | $3.31 | $4,077.92 |
DisclosureSEC source: 0001641172-25-025741 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 148,011 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on August 25, 2025 were purchased in multiple transactions at prices ranging from $3.30 to $3.31 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 22, 2025 Filed Aug 22, 2025 20:12 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,200 | $3.33 | $3,996.00 |
DisclosureSEC source: 0001641172-25-025212 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 146,779 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 20:12 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,200 | $3.45 | $4,140.00 |
DisclosureSEC source: 0001641172-25-025212 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 145,579 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 01:02 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 100 | $4.42 | $442.00 |
DisclosureSEC source: 0001641172-25-019805 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 144,379 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 26, 2025 Filed Jun 26, 2025 21:00 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 22 | $4.50 | $99.00 |
DisclosureSEC source: 0001641172-25-016686 · ownership.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 144,279 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 25, 2025 Filed Jun 26, 2025 21:00 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 2 | $4.50 | $9.00 |
DisclosureSEC source: 0001641172-25-016686 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 144,257 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 24, 2025 Filed Jun 26, 2025 21:00 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 20 | $4.46 | $89.20 |
DisclosureSEC source: 0001641172-25-016686 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 144,255 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on June 24, 2025 were purchased in multiple transactions at prices ranging from $4.35 to $4.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 23, 2025 Filed Jun 24, 2025 18:11 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 677 | $4.12 | $2,789.24 |
DisclosureSEC source: 0001641172-25-016273 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 144,235 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 18:11 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 888 | $4.13 | $3,667.44 |
DisclosureSEC source: 0001641172-25-016273 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 143,558 F2 · price: The reported price in Column 4 is an average purchase price. The shares acquired on June 20, 2025 were purchased in multiple transactions at prices ranging from $4.095 to $4.23 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 18, 2025 Filed Jun 20, 2025 15:08 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 635 | $4.04 | $2,565.40 |
DisclosureSEC source: 0001641172-25-015773 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 142,670 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on June 18, 2025 were purchased in multiple transactions at prices ranging from $4.00 to $4.06 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 14:07 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,280 | $3.88 | $4,966.40 |
DisclosureSEC source: 0001641172-25-014999 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 142,035 F3 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on June 12, 2025 were purchased in multiple transactions at prices ranging from $3.81 to $3.89 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 14:07 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,270 | $3.83 | $4,864.10 |
DisclosureSEC source: 0001641172-25-014999 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 140,755 F2 · price: The reported price in Column 4 is a weighted average purchase price. The shares acquired on June 11, 2025 were purchased in multiple transactions at prices ranging from $3.81 to $3.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 17:50 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,282 | $3.91 | $5,012.62 |
DisclosureSEC source: 0001641172-25-014660 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 139,485 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 17:50 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 13 | $3.83 | $49.79 |
DisclosureSEC source: 0001641172-25-014660 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 138,203 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| June 02, 2025 Filed Jun 3, 2025 00:35 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,327 | $3.95 | $5,241.65 |
DisclosureSEC source: 0001641172-25-013330 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 138,190 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 00:35 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,305 | $3.90 | $5,089.50 |
DisclosureSEC source: 0001641172-25-013330 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 136,863 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| May 29, 2025 Filed May 30, 2025 16:56 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,300 | $3.69 | $4,797.00 |
DisclosureSEC source: 0001641172-25-012976 · ownership.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 135,558 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| May 28, 2025 Filed May 30, 2025 16:56 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | PurchaseCommon Stock | 1,275 | $3.90 | $4,972.50 |
DisclosureSEC source: 0001641172-25-012976 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 134,258 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 01:01 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | GrantEmployee Stock Option · Derivative | 900,000 | $0.00 Strike: $4.25 | $0.00 |
DisclosureSEC source: 0001641172-25-006736 · ownership.xml · derivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 900,000 Underlying: Class A · 900,000 shares Expires 2035-04-28 F1 · security: 400,000 Class A Shares will vest as follows: 200,000 shares vest immediately on grant and the remainder vest in 22 equal monthly installments of 8,333 shares for each complete subsequent month of Continuous Service (as defined in the 2022 Equity Performance Plan) and 8,341 will vest on March 15, 2027. F2 · security: 500,000 Class A Shares are performance-based and vest upon the date on which either of the following occurs during the Exercisability Period (as defined in the Plan and option agreement: (x) a Class A Share has traded in the market on which the Class A Shares are listed for at least thirty (30) trading days at an average price of $20.00 or more, whether consecutive or non-consecutive, or (y) there are distributions of cash, stock or other property by the Company on the Class A Shares, at a value of $20.00 or more in the aggregate per Class A Share. Read SEC document |
| April 28, 2025 Filed Apr 30, 2025 01:01 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Disposition to issuerRSU · Derivative | 900,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-006736 · ownership.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A · 900,000 shares Expires 2025-04-28 Read SEC document |
| April 11, 2025 Filed Apr 15, 2025 00:23 UTC | MDB Capital Holdings, LLC MDBH? · Entity 7469 | PurchaseCommon Stock | 1,625 | $5.00 | $8,125.00 |
DisclosureSEC source: 0001641172-25-004656 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 132,983 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| April 07, 2025 Filed Apr 9, 2025 22:16 UTC | MDB Capital Holdings, LLC MDBH? · Entity 7469 | PurchaseCommon Stock | 1,425 | $4.80 | $6,840.00 |
DisclosureSEC source: 0001641172-25-003463 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · Co-Founder · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · CUST Disclosed balance after: 131,358 F1 · ownership.direct: Held as custodian for minor Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionRSU · Derivative | 50,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-050947 · ownership.xml · derivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Class A · 50,000 shares Expires 2024-10-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 21, 2024 Filed Dec 20, 2024 17:36 UTC | MDB Capital Holdings, LLC MDBH · Entity 7469 | Exercise / conversionCommon Stock | 50,000 | $6.81 | $340,500.00 |
DisclosureSEC source: 0001493152-24-050947 · ownership.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director · CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 22:57 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $16.31 | $0.00 |
DisclosureSEC source: 0001209191-20-002061 · doc4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2030-01-02 F1 · shares: Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy. Read SEC document |
| December 31, 2019 Filed Dec 31, 2019 23:26 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 9,000 | $15.71 | $141,390.00 |
DisclosureSEC source: 0001209191-19-062325 · doc4.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.60 to $15.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 31, 2019 Filed Dec 31, 2019 23:26 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 6,700 | $15.77 | $105,659.00 |
DisclosureSEC source: 0001209191-19-062325 · doc4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 768,503 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.60 to $16.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 23:26 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 9,000 | $17.24 | $155,160.00 |
DisclosureSEC source: 0001209191-19-062325 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 775,203 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.56, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 26, 2019 Filed Dec 27, 2019 21:39 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 19,647 | $17.53 | $344,411.91 |
DisclosureSEC source: 0001209191-19-062031 · doc4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 784,203 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.35 to $17.84, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 23, 2019 Filed Dec 27, 2019 21:39 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 17,000 | $16.82 | $285,940.00 |
DisclosureSEC source: 0001209191-19-062031 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 803,850 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.44 to $17.00, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 19, 2019 Filed Dec 19, 2019 22:35 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 4,000 | $17.00 | $68,000.00 |
DisclosureSEC source: 0001209191-19-061377 · doc4.xml · nonDerivative · entry 4 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 820,850 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 to $17.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 22:35 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | SaleCommon Stock | 20,732 | $15.73 | $326,114.36 |
DisclosureSEC source: 0001209191-19-061377 · doc4.xml · nonDerivative · entry 3 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 824,850 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.12 to $16.38, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 12, 2019 Filed Dec 19, 2019 22:35 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | OtherCommon Stock | 755,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061377 · doc4.xml · nonDerivative · entry 2 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 845,582 F1 · kind: Pro rata distribution from MDB Capital Group, LLC ("MDB"). F3 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 12, 2019 Filed Dec 19, 2019 22:35 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | OtherCommon Stock | 1,007,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-061377 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · kind: Pro rata distribution from MDB Capital Group, LLC ("MDB"). F2 · ownership.nature: The record owner of these securities is MDB. The reporting person is the Chief Executive Officer of MDB. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein and inclusion of these securities in the report shall not be an admission of beneficial ownership for purposes of Section 16 or any other purposes. Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 23:38 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001209191-19-001330 · doc4.xml · derivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2026-01-02 Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 21:20 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 18,521 | $4.64 | $85,937.44 |
DisclosureSEC source: 0001209191-19-000270 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 89,602 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.56 to $4.70, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4. F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 26, 2018 Filed Dec 27, 2018 21:28 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 19,647 | $4.29 | $84,285.63 |
DisclosureSEC source: 0001209191-18-064186 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 71,081 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.38, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 21, 2018 Filed Dec 26, 2018 21:09 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 17,200 | $4.53 | $77,916.00 |
DisclosureSEC source: 0001209191-18-064086 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 51,434 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.33 to $4.66, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 20, 2018 Filed Dec 21, 2018 12:22 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 9,438 | $4.74 | $44,736.12 |
DisclosureSEC source: 0001209191-18-063800 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 34,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.60 to $4.85, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4 F2 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:17 UTC | Cue Biopharma, Inc. CUE · Entity 6301 | PurchaseCommon Stock | 400 | $5.00 | $2,000.00 |
DisclosureSEC source: 0001209191-18-063658 · doc4.xml · nonDerivative · entry 1 MARLETT CHRISTOPHER A · CIK 0000897744 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 24,796 F1 · ownership.nature: Held by the Christopher A. Marlett Living Trust, of which the reporting person is sole trustee. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.